Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GDXJ vs GSK✓SelectedUSD · GSKGDXJ vs GSK performance historyLatest closeAs of-0.60%11/13
Stock and ETF performance explorer

GDXJ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+37.8%
GSK return
+183.3%
Excess return
-145.5%
Maximum drawdown
-88.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.6%+0.5%-1.1%-0.8%
7D-8.1%+1.1%-9.2%-8.5%
30D-5.5%+6.3%-11.8%-7.9%
3M-14.6%+1.8%-16.4%-15.5%
6M-23.2%+1.7%-24.9%-24.3%
YTD-13.0%+6.5%-19.5%-16.3%
1Y+2.8%+9.5%-6.7%-2.4%
3Y+221.5%+65.3%+156.2%+144.5%
5Y+123.4%+43.7%+79.6%+78.8%
10Y+238.2%+104.1%+134.0%+124.7%
All+37.8%+183.3%-145.5%-27.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling